纳特雷克松用于眼部应用:关于纳米载体,专利和证据分析的小更新
1University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, Punjab 160014, India.
Molecular pharmaceutics
|October 30, 2025
概括
先进的纳米配方增强了纳尔特雷克森 (NTX) 眼部的输送,改善了眼部疾病的溶解性,保留性和疗效. 这些系统显示出更安全,更有效的眼睛治疗的巨大潜力.
科学领域:
- 眼科医生 眼科 眼科
- 纳米技术纳米技术
- 药理学 药理学是指药理学的学科.
背景情况:
- 眼部药物输送面临着重要的解剖和生理障碍.
- 纳尔特雷克松 (NTX) 是一种阿片类药物对手,具有抗炎和免疫调节性质,有利于眼科治疗.
研究的目的:
- 系统地审查基于纳尔特雷 (NTX) 的眼部输送系统的进展.
- 评估纳米配方NTX在各种眼部疾病中的有效性和安全性.
主要方法:
- 在PubMed,谷歌学者和科学网络 (2006-2024) 中进行了全面的文献搜索.
- 包括14项原始研究和4项专利,重点关注NTX纳米配方 (niosomes,水凝,in situ凝膜,聚合物矩阵).
- 使用GRADE框架评估证据确定性.
主要成果:
- 纳米配方显著改善了NTX溶解性,角膜前保留,角膜透,持续释放和光稳定性.
- 证据的高确定性支持增强的可溶性,保留,持续释放和安全性.
- 中等确定性支持NTX在糖尿病角膜病变,眼产生,角膜愈合和眼部生物可用性方面的疗效.
结论:
- 纳米配制的NTX在治疗各种眼部疾病方面具有相当大的潜力.
- 先进的输送系统对于优化治疗结果和最大限度地减少眼部治疗中的副作用至关重要.
- NTX纳米配方为改善眼部药物输送提供了一个有希望的策略.
相关概念视频
Drug Delivery: Miscellaneous Routes
690
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
690
Opioid Receptors: Overview
3.8K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
3.8K


